# Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

> **NCT00750009** · PHASE3 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 583 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **OTHER:** educational intervention

## Key facts

- **NCT ID:** NCT00750009
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 583 (ACTUAL)
- **Last updated:** 2020-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750009, "Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00750009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*